Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Glaser

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Dermatology|November 1, 2018
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled TrialsDavid M Pariser, Adelaide A Hebert, Janice Drew, et al.
Multiple Sclerosis and Related Disorders|June 27, 2024
Socioeconomic status and quality of multiple sclerosis care in SwedenAnna He, Ali Manouchehrinia, Anna Glaser, et al.
Journal of the American Academy of Dermatology|February 20, 2007
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyNicholas J Lowe, Dee Anna Glaser, Nina Eadie, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 29, 2015
Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficitDee Anna Glaser, Jeffrey M Kenkel, Deepali Paradkar-Mitragotri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2023
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosisAnna H He, Ali Manouchehrinia, Anna Glaser, et al.
Rheumatology (Oxford, England)|December 15, 2017
Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytesKavitha Ramanathan, Anna Glaser, Hanna Lythgoe, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 31, 2024
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary SweatingStacy Smith, Dee Anna Glaser, Lawerence J Green, et al.
Annals of Clinical and Translational Neurology|May 13, 2022
Copy number variations across the blood-brain barrier in multiple sclerosisSahl Khalid Bedri, Björn Evertsson, Mohsen Khademi, et al.
Neuro-Degenerative Diseases|August 16, 2006
Clinical and molecular aspects of frontotemporal dementiaSusanne Froelich-Fabre, Lena Skoglund, Jovanka Ostojic, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2017
Multiple sclerosis treatment effects on plasma cytokine receptor levelsSahl Khalid Bedri, Katharina Fink, Ali Manouchehrinia, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Dermatology|November 1, 2018
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled TrialsDavid M Pariser, Adelaide A Hebert, Janice Drew, et al.
Multiple Sclerosis and Related Disorders|June 27, 2024
Socioeconomic status and quality of multiple sclerosis care in SwedenAnna He, Ali Manouchehrinia, Anna Glaser, et al.
Journal of the American Academy of Dermatology|February 20, 2007
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyNicholas J Lowe, Dee Anna Glaser, Nina Eadie, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 29, 2015
Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficitDee Anna Glaser, Jeffrey M Kenkel, Deepali Paradkar-Mitragotri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2023
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosisAnna H He, Ali Manouchehrinia, Anna Glaser, et al.
Rheumatology (Oxford, England)|December 15, 2017
Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytesKavitha Ramanathan, Anna Glaser, Hanna Lythgoe, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 31, 2024
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary SweatingStacy Smith, Dee Anna Glaser, Lawerence J Green, et al.
Annals of Clinical and Translational Neurology|May 13, 2022
Copy number variations across the blood-brain barrier in multiple sclerosisSahl Khalid Bedri, Björn Evertsson, Mohsen Khademi, et al.
Neuro-Degenerative Diseases|August 16, 2006
Clinical and molecular aspects of frontotemporal dementiaSusanne Froelich-Fabre, Lena Skoglund, Jovanka Ostojic, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2017
Multiple sclerosis treatment effects on plasma cytokine receptor levelsSahl Khalid Bedri, Katharina Fink, Ali Manouchehrinia, et al.
Pageof 10